List of Xyzal Allergy 24hr drug patents

Xyzal Allergy 24Hr is owned by Chattem Sanofi.

Xyzal Allergy 24Hr contains Levocetirizine Dihydrochloride.

Xyzal Allergy 24Hr has a total of 1 drug patent out of which 0 drug patents have expired.

Xyzal Allergy 24Hr was authorised for market use on 31 January, 2017.

Xyzal Allergy 24Hr is available in solution;oral dosage forms.

The generics of Xyzal Allergy 24Hr are possible to be released after 16 October, 2027.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8633194 CHATTEM SANOFI Pharmaceutical composition of piperazine derivatives
Oct, 2027

(4 years from now)

Drugs and Companies using LEVOCETIRIZINE DIHYDROCHLORIDE ingredient

Market Authorisation Date: 31 January, 2017

Treatment: NA

Dosage: SOLUTION;ORAL

How can I launch a generic of XYZAL ALLERGY 24HR before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in